Biomarkers for tuberculosis: the case for lipoarabinomannan.


Journal

ERJ open research
ISSN: 2312-0541
Titre abrégé: ERJ Open Res
Pays: England
ID NLM: 101671641

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 20 07 2018
accepted: 05 11 2018
entrez: 19 2 2019
pubmed: 19 2 2019
medline: 19 2 2019
Statut: epublish

Résumé

Tuberculosis (TB) is considered the most onerous of infectious diseases according to recent reports from the World Health Organization. Available tests for TB diagnosis present severe limitations, and a reliable point-of-care (POC) diagnostic test does not exist. Neither is there a test to discern between the different stages of TB, and in particular to predict which patients with

Identifiants

pubmed: 30775376
doi: 10.1183/23120541.00115-2018
pii: 00115-2018
pmc: PMC6368998
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

Conflict of interest: M. Correia-Neves has nothing to disclose. Conflict of interest: G. Fröberg has nothing to disclose. Conflict of interest: L. Korshun has nothing to disclose. Conflict of interest: S. Viegas has nothing to disclose. Conflict of interest: P. Vaz reports receiving grants from the Ariel Foundation during the conduct of the study. Conflict of interest: N. Ramanlal reports receiving grants from the Ariel Foundation during the conduct of the study. Conflict of interest: J. Bruchfeld has nothing to disclose. Conflict of interest: B. Hamasur has nothing to disclose. Conflict of interest: P. Brennan has nothing to disclose. Conflict of interest: G. Källenius reports receiving grants from the Optimus Foundation during the conduct of the study and owns shares in TBDiadirect AB.

Références

Int J Tuberc Lung Dis. 1999 Mar;3(3):231-8
pubmed: 10094325
J Microbiol Methods. 2001 May;45(1):41-52
pubmed: 11295196
Scand J Infect Dis. 2001;33(4):279-84
pubmed: 11345220
Scand J Infect Dis. 2002;34(2):97-103
pubmed: 11928861
Scand J Immunol. 2002 Jun;55(6):639-45
pubmed: 12028568
Scand J Infect Dis. 2002;34(3):167-71
pubmed: 12030387
J Infect Dis. 2003 Feb 1;187(3):513-7
pubmed: 12552438
Mol Microbiol. 2004 Jul;53(2):391-403
pubmed: 15228522
Clin Exp Immunol. 2004 Oct;138(1):30-8
pubmed: 15373902
Am Fam Physician. 2005 Mar 15;71(6):1153-62
pubmed: 15791892
Trans R Soc Trop Med Hyg. 2005 Dec;99(12):893-900
pubmed: 16139316
Infect Immun. 2005 Oct;73(10):6711-20
pubmed: 16177348
Int J Tuberc Lung Dis. 2007 Jun;11(6):624-31
pubmed: 17519093
J Biol Chem. 1991 May 25;266(15):9652-60
pubmed: 1903393
Lancet Infect Dis. 2009 Mar;9(3):162-72
pubmed: 19246020
PLoS One. 2009;4(3):e4689
pubmed: 19277111
Annu Rev Immunol. 2009;27:393-422
pubmed: 19302046
Clin Chim Acta. 2009 Jun 27;404(2):140-3
pubmed: 19332047
BMC Pulm Med. 2009 May 16;9:21
pubmed: 19445695
J Acquir Immune Defic Syndr. 2009 Oct 1;52(2):145-51
pubmed: 19692904
BMC Infect Dis. 2009 Aug 28;9:141
pubmed: 19715562
Int J Tuberc Lung Dis. 2009 Oct;13(10):1253-9
pubmed: 19793430
Nat Rev Microbiol. 2009 Dec;7(12):845-55
pubmed: 19855401
Cerebrospinal Fluid Res. 2009 Nov 02;6:13
pubmed: 19878608
AIDS. 2009 Sep 10;23(14):1875-80
pubmed: 20108382
PLoS One. 2010 Mar 24;5(3):e9848
pubmed: 20352098
J Clin Microbiol. 2010 Aug;48(8):2972-4
pubmed: 20534796
J Biol Chem. 1990 Jun 5;265(16):9272-9
pubmed: 2111816
J Proteome Res. 2011 Mar 4;10(3):1316-22
pubmed: 21247063
Tuberculosis (Edinb). 2011 May;91(3):250-6
pubmed: 21393062
PLoS One. 2011 Mar 29;6(3):e17984
pubmed: 21479236
Eur Respir J. 2011 Dec;38(6):1398-405
pubmed: 21700601
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):219-23
pubmed: 21765364
Clin Vaccine Immunol. 2011 Oct;18(10):1616-27
pubmed: 21832100
PLoS Med. 2011 Aug;8(8):e1001062
pubmed: 21857806
J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):463-8
pubmed: 21963941
Clin Vaccine Immunol. 2012 Feb;19(2):198-208
pubmed: 22169090
PLoS One. 2012;7(2):e32340
pubmed: 22363820
BMC Infect Dis. 2012 Feb 27;12:47
pubmed: 22369353
Biomark Insights. 2012;7:1-8
pubmed: 22403482
Future Microbiol. 2012 May;7(5):559-64
pubmed: 22568711
Biosens Bioelectron. 2012 Oct-Dec;38(1):421-4
pubmed: 22709935
Tuberculosis (Edinb). 2012 Sep;92(5):407-16
pubmed: 22710249
Int J Tuberc Lung Dis. 2012 Aug;16(8):1108-12
pubmed: 22710609
PLoS One. 2012;7(8):e42515
pubmed: 22880012
BMC Immunol. 2013;14 Suppl 1:S3
pubmed: 23458564
Adv Exp Med Biol. 2013;783:225-50
pubmed: 23468112
Tuberculosis (Edinb). 2013 May;93(3):301-7
pubmed: 23507184
Clin Vaccine Immunol. 2013 Sep;20(9):1479-82
pubmed: 23825194
BMC Infect Dis. 2013 Sep 03;13:407
pubmed: 24004840
PLoS One. 2013 Sep 04;8(9):e73076
pubmed: 24023812
Clin Microbiol Rev. 2014 Jan;27(1):3-20
pubmed: 24396134
Int J Tuberc Lung Dis. 2014 Feb;18(2):205-10
pubmed: 24429314
BMC Infect Dis. 2014 Jan 31;14:53
pubmed: 24484441
Trop Med Int Health. 2014 Jun;19(6):734-742
pubmed: 24684481
Eur Respir J. 2014 Jun;43(6):1719-29
pubmed: 24743962
Lancet Glob Health. 2014 May;2(5):e278-84
pubmed: 24818083
PLoS One. 2014 Jun 11;9(2):e98938
pubmed: 24918450
PLoS One. 2014 Jul 07;9(7):e101459
pubmed: 25000489
Immunity. 2014 Sep 18;41(3):402-413
pubmed: 25176311
PLoS One. 2014 Sep 05;9(9):e106796
pubmed: 25192196
J Biol Chem. 2014 Oct 31;289(44):30249-56
pubmed: 25231986
J Clin Microbiol. 2015 Feb;53(2):504-10
pubmed: 25428147
Immunol Rev. 2015 Mar;264(1):167-81
pubmed: 25703559
BMJ Open. 2015 Apr 15;5(4):e006833
pubmed: 25877271
BMC Infect Dis. 2015 Feb 15;15:62
pubmed: 25888317
PLoS One. 2015 Apr 21;10(4):e0123323
pubmed: 25897661
PLoS One. 2015 Apr 23;10(4):e0123457
pubmed: 25905641
Sci Rep. 2015 May 15;5:10281
pubmed: 25975873
Tuberculosis (Edinb). 2015 Jul;95(4):373-84
pubmed: 26038289
Tuberculosis (Edinb). 2015 Jul;95(4):452-62
pubmed: 26043674
Eur Respir J. 2015 Sep;46(3):761-70
pubmed: 26113682
Tuberculosis (Edinb). 2016 Jan;96:120-30
pubmed: 26586646
PLoS One. 2015 Dec 03;10(12):e0144088
pubmed: 26633829
J Clin Microbiol. 2016 Jan;54(1):241-2
pubmed: 26719583
Am J Respir Crit Care Med. 2016 Aug 1;194(3):345-55
pubmed: 26882070
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):180-5
pubmed: 26884498
Lancet. 2016 Mar 19;387(10024):1187-97
pubmed: 26970721
BMC Med. 2016 Mar 23;14:53
pubmed: 27007773
Lancet. 2016 Jun 4;387(10035):2312-2322
pubmed: 27017310
J Infect Dis. 2016 Jul 15;214(2):300-10
pubmed: 27056953
Nat Commun. 2016 Apr 12;7:11290
pubmed: 27068708
Cochrane Database Syst Rev. 2016 May 10;(5):CD011420
pubmed: 27163343
Infect Dis Rep. 2016 Jun 24;8(2):6568
pubmed: 27403267
J Biol Chem. 2016 Sep 2;291(36):18867-79
pubmed: 27417139
Cell. 2016 Oct 6;167(2):433-443.e14
pubmed: 27667685
PLoS Med. 2016 Oct 25;13(10):e1002152
pubmed: 27780211
Int J Infect Dis. 2017 Mar;56:258-262
pubmed: 27836792
Eur Respir J. 2016 Dec;48(6):1751-1763
pubmed: 27836953
Tuberculosis (Edinb). 2016 Dec;101:102-113
pubmed: 27865379
Analyst. 2016 Dec 19;142(1):186-196
pubmed: 27924983
Analyst. 2016 Dec 19;142(1):177-185
pubmed: 27934985
BMC Res Notes. 2017 Jan 31;10(1):74
pubmed: 28137314
BMC Infect Dis. 2017 Mar 9;17(1):200
pubmed: 28274215
BMC Med. 2017 Mar 21;15(1):67
pubmed: 28320384
Int J Infect Dis. 2017 Jun;59:96-102
pubmed: 28457751
BMC Infect Dis. 2017 May 12;17(1):339
pubmed: 28499418
Tuberculosis (Edinb). 2017 Jul;105:28-34
pubmed: 28610785
Am J Respir Crit Care Med. 2017 Sep 1;196(5):638-648
pubmed: 28737960
Am J Respir Crit Care Med. 2017 Sep 1;196(5):546-547
pubmed: 28763239
ACS Omega. 2017 Jul 31;2(7):3921-3930
pubmed: 28782053
Sci Transl Med. 2017 Dec 13;9(420):null
pubmed: 29237757
Am J Respir Crit Care Med. 2018 Apr 6;:
pubmed: 29624071
Lancet. 2018 Jul 28;392(10144):292-301
pubmed: 30032978
Am Rev Respir Dis. 1986 Aug;134(2):205-9
pubmed: 3090914
J Biol Chem. 1986 Sep 15;261(26):12345-51
pubmed: 3091602
Clin Chem. 1988 Jan;34(1):27-33
pubmed: 3338181
J Biol Chem. 1988 Mar 25;263(9):4092-7
pubmed: 3346237
Am J Med. 1970 Mar;48(3):325-31
pubmed: 5435646
Clin Exp Immunol. 1993 Oct;94(1):57-63
pubmed: 8403518
Clin Diagn Lab Immunol. 1997 Jan;4(1):49-56
pubmed: 9008280
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15688-93
pubmed: 9861031

Auteurs

Margarida Correia-Neves (M)

Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Gabrielle Fröberg (G)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Liudmyla Korshun (L)

Biopromic AB, Solna, Sweden.

Sofia Viegas (S)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.

Paula Vaz (P)

Instituto Nacional de Saúde, Ministério da Saúde, Maputo, Mozambique.
Fundação Ariel Glaser Contra o SIDA Pediátrico, Maputo, Mozambique.

Nehaben Ramanlal (N)

Fundação Ariel Glaser Contra o SIDA Pediátrico, Maputo, Mozambique.

Judith Bruchfeld (J)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Dept of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Beston Hamasur (B)

Biopromic AB, Solna, Sweden.
Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Patrick Brennan (P)

Dept of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.

Gunilla Källenius (G)

Division of Infectious Diseases, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Classifications MeSH